Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
Recruiting · NCT06923072 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement | Arterial Occlusive Diseases, Skin and Connective Tissue Diseases, cardiovascular disorder, malignant atrophic papulosis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 2 | 2026-09-18 | NCT06923072 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |